Clinical Trial Update: Adductor Canal Block Versus Liposomal Bupivacaine in TKA [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial comparing adductor canal block to liposomal bupivacaine for post-operative pain control in total knee arthroplasty has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Total Knee Arthroplasty

Drugs mentioned

• Adductor canal block
• Liposomal bupivacaine (bupivacaine liposome injectable suspension)

Snippet

Sponsor: Good Samaritan Regional Medical Center, Oregon | Conditions: Total Knee Arthroplasty, Post-operative Pain Control | Phase 4 | Status: COMPLETED